Sint-Genesius-Rode, Belgium

Cecile Casterman

This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignees: Vrije Universiteit Brussel, Vrije Universiteit. Active years: 1998-2010.

USPTO Granted Patents = 10 

% Patents Active = 70.0

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 879(Granted Patents)


Company Filing History:


Years Active: 1998-2010

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Cecile Casterman

Introduction

Cecile Casterman is a prominent inventor based in Sint-Genesius-Rode, Belgium. She has made significant contributions to the field of immunology, holding a total of 10 patents. Her work focuses on developing innovative methods and immunoglobulins that have the potential to advance medical science.

Latest Patents

Among her latest patents is a method for screening a library of VHH polypeptides. This method involves subjecting a library of VHH polypeptides to antigen-affinity selection with the antigen to identify those that bind effectively. Another notable patent relates to immunoglobulins devoid of light chains. This invention describes an immunoglobulin with a specific antigen recognition capability, derived from a heavy-chain immunoglobulin that naturally lacks light chains. The immunoglobulin is designed to have a constant region that includes part of a human antibody's constant region.

Career Highlights

Cecile has worked at prestigious institutions such as Vrije Universiteit Brussel and Vrije Universiteit. Her research and innovations have contributed to the understanding and development of therapeutic antibodies, showcasing her expertise in the field.

Collaborations

Cecile has collaborated with various professionals, including her coworker Raymond Hamers, to further her research and innovations in immunology.

Conclusion

Cecile Casterman's contributions to the field of immunology through her patents and collaborations highlight her role as a leading inventor. Her innovative methods and immunoglobulins continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…